Experimental Study of a Radiopharmaceutical Agent Based on Modified Fatty Acid Labeled with Technetium-99m

Bibliographic Details
Parent link:Bulletin of Experimental Biology and Medicine
Vol. 162, iss. 6.— 2017.— [P. 746-749]
Corporate Authors: Национальный исследовательский Томский политехнический университет (ТПУ) Физико-технический институт (ФТИ) Лаборатория радиационного контроля № 31 (Лаборатория РК № 31), Национальный исследовательский Томский политехнический университет (ТПУ) Институт физики высоких технологий (ИФВТ) Кафедра биотехнологии и органической химии (БИОХ)
Other Authors: Sazonova S. I. Svetlana Ivanovna, Iljyushenkova Yu. N. Yuliya Nikolaevna, Lishmanov Yu. B. Yury Borisovich, Tsibulnikov S. Yu. Sergey Yurjevich, Skuridin V. S. Viktor Sergeyevich, Nesterov E. A. Evgeny Alexandrovich, Varlamova N. V. Natalya Valeryevna, Tagirova E. A. Ekaterina Alekseevna, Filimonov V. D. Viktor Dmitrievich, Belyanin M. L. Maksim L'vovich, Stepanova E. V. Elena Vladimirovna, Minin S. M. Stanislav Mikhaylovich
Summary:Title screen
Using rat model of coronary occlusion, we studied pharmacokinetics and the efficiency of a new radiopharmaceutical agent 99mTc-PDA-DTPA intended for diagnostics of changes in myocardial metabolism and its analogue 123I-PMPDA. 99mTc-PDA-DTPA was eliminated mostly by the kidneys and maximal concentration in the heart was attained within 60 min after intravenous injection; no accumulation in the area of myocardial infarction was observed. The studied substance was inferior to its analogue 123I-PMPDA by the quality of scintigraphic visualization of the heart.
Режим доступа: по договору с организацией-держателем ресурса
Published: 2017
Subjects:
Online Access:https://doi.org/10.1007/s10517-017-3703-4
Format: Electronic Book Chapter
KOHA link:https://koha.lib.tpu.ru/cgi-bin/koha/opac-detail.pl?biblionumber=655917